A2G (p.Ala2Gly) variant of CDK9 (Cyclin-dependent kinase 9)
A2G (p.Ala2Gly) in CDK9 (Cyclin-dependent kinase 9) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data, published literature, and structural context.
A2G (p.Ala2Gly) variant details
- p.Ala2Gly
- gnomAD 9-127785811-C-G
- Missense
- Variant Prioritization Score for Impact Estimate 0.388
- CADD 15.80
- SIFT 0.51
- Population evidence available
- Structural context available
- Literature evidence available